Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Dow
AstraZeneca
Harvard Business School
Moodys

Last Updated: October 7, 2022

PENTOSTATIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Pentostatin patents expire, and what generic alternatives are available?

Pentostatin is a drug marketed by Rising and West-ward Pharms Int and is included in two NDAs.

The generic ingredient in PENTOSTATIN is pentostatin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pentostatin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pentostatin

A generic version of PENTOSTATIN was approved as pentostatin by WEST-WARD PHARMS INT on August 7th, 2007.

  Try it Free

Drug patent expirations by year for PENTOSTATIN
Drug Prices for PENTOSTATIN

See drug prices for PENTOSTATIN

Recent Clinical Trials for PENTOSTATIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Scripps HealthPhase 2
City of Hope Medical CenterPhase 1
California Institute for Regenerative Medicine (CIRM)Phase 1

See all PENTOSTATIN clinical trials

Medical Subject Heading (MeSH) Categories for PENTOSTATIN

US Patents and Regulatory Information for PENTOSTATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising PENTOSTATIN pentostatin INJECTABLE;INJECTION 203554-001 Sep 19, 2014 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
West-ward Pharms Int PENTOSTATIN pentostatin INJECTABLE;INJECTION 077841-001 Aug 7, 2007 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Moodys
McKinsey
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.